HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mateusz Wierzbicki Selected Research

Adenocarcinoma

11/2021Effects of Metallic and Carbon-Based Nanomaterials on Human Pancreatic Cancer Cell Lines AsPC-1 and BxPC-3.
3/2019Nanocomplexes of Graphene Oxide and Platinum Nanoparticles against Colorectal Cancer Colo205, HT-29, HTC-116, SW480, Liver Cancer HepG2, Human Breast Cancer MCF-7, and Adenocarcinoma LNCaP and Human Cervical Hela B Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mateusz Wierzbicki Research Topics

Disease

22Neoplasms (Cancer)
06/2023 - 01/2011
19Glioblastoma (Glioblastoma Multiforme)
06/2023 - 01/2011
9Glioma (Gliomas)
01/2023 - 01/2013
5Liver Neoplasms (Liver Cancer)
11/2023 - 01/2016
5Hepatocellular Carcinoma (Hepatoma)
06/2023 - 01/2015
4Breast Neoplasms (Breast Cancer)
06/2023 - 03/2019
3Mastitis
01/2024 - 04/2019
3Brain Neoplasms (Brain Tumor)
10/2017 - 01/2011
2Adenocarcinoma
11/2021 - 03/2019
2Necrosis
12/2019 - 01/2013
2Body Weight (Weight, Body)
10/2016 - 12/2015
1Inflammation (Inflammations)
11/2023
1Digital Dermatitis
03/2023
1Cytokine Release Syndrome
01/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2021
1Bovine Mastitis
06/2021
1Colorectal Neoplasms (Colorectal Cancer)
03/2019
1Drug-Related Side Effects and Adverse Reactions
10/2017
1Hemolysis
09/2017
1type 2 alpha 1 Collagenopathy
01/2015

Drug/Important Bio-Agent (IBA)

15GraphiteIBA
01/2023 - 01/2013
12graphene oxideIBA
01/2023 - 01/2015
10Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2015
8DiamondIBA
06/2023 - 01/2015
7CarbonIBA
11/2021 - 01/2011
3PlatinumIBA
06/2023 - 10/2017
3Messenger RNA (mRNA)IBA
01/2023 - 10/2017
3Interleukin-8 (Interleukin 8)IBA
01/2023 - 10/2018
3Antineoplastic Agents (Antineoplastics)IBA
08/2022 - 01/2016
3SilverIBA
06/2021 - 01/2015
3OxidesIBA
01/2021 - 12/2018
2fullerene C60IBA
11/2023 - 01/2019
2Tissue Inhibitor of Metalloproteinase-2IBA
01/2023 - 11/2021
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2023 - 10/2018
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2023 - 11/2021
2Interleukin-6 (Interleukin 6)IBA
01/2023 - 10/2018
2CopperIBA
06/2021 - 04/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2018 - 01/2017
2Cisplatin (Platino)FDA LinkGeneric
10/2017 - 01/2017
2Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2017 - 01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2024
1Iodine-125IBA
06/2023
1Therapeutic UsesIBA
06/2023
1Anti-Infective Agents (Microbicides)IBA
03/2023
1Trastuzumab (Herceptin)FDA Link
03/2023
1GoldIBA
03/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2023
1CytokinesIBA
01/2023
1FullerenesIBA
01/2023
1Metalloproteases (Metalloproteinases)IBA
01/2023
1MicroRNAs (MicroRNA)IBA
09/2021
1Ion Channels (Ion Channel)IBA
01/2021
1Melitten (Melittin)IBA
12/2019
1Bee Venoms (Bee Venom)IBA
12/2019
1Cytochrome P-450 CYP2C9IBA
12/2019
1CyclinsIBA
04/2019
1diazonaphthalenedisulfonic acid (NDS)IBA
04/2019
1MetalsIBA
04/2019
1EnzymesIBA
03/2019
1SaltsIBA
03/2019
1Bromodeoxyuridine (BrdU)IBA
03/2019
1Oxygen (Dioxygen)IBA
12/2018
1Reactive Nitrogen SpeciesIBA
10/2018
1Transcription Factors (Transcription Factor)IBA
10/2018
1Caspase 3 (Caspase-3)IBA
10/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1CateninsIBA
01/2017
1CurcuminIBA
01/2016
1Arginine (L-Arginine)FDA Link
10/2015
1Proline (L-Proline)FDA Link
10/2015
1Hydroxyproline (4 Hydroxyproline)IBA
01/2015

Therapy/Procedure

11Therapeutics
06/2023 - 01/2013
3Aftercare (After-Treatment)
01/2023 - 01/2021
1Complementary Therapies (Alternative Medicine)
06/2021
1Injections
09/2017
1Intraperitoneal Injections
12/2015